Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Page 2

Sigilon signals $100m IPO target
Chronic illness drug developer Sigilon Therapeutics, co-founded by MIT and UIC researchers, has filed to go public after raising almost $200m in funding.
Start Codon decodes $20m fund
The University of Cambridge-aligned healthcare and life sciences accelerator has added Novartis as a strategic partner.
Bridge Medicines crosses $10m
Existing backers Takeda, Deerfield and Bay City Capital have provided $10m to help progress research from multiple institutions.
Metagenomi sets out $65m series A
Gene editing technology developer Metagenomi advances research from UC Berkeley and has raised a series A co-led by Bayer.
Daily deal net: November 13, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Buoy Health marks off series C funding
Co-founded by a team of doctors and computer scientists out of Harvard Innovation Labs, Buoy Health has grown its overall financing to $66.5m.
Boston Children’s catches $65m from Deerfield
Boston Children’s Hospital is the 18th university or research institute to receive academic bridge funding from Deerfield Management.
Synendos Therapeutics sews up $21.9m
Partly based on University of Bern research, Synendos aims to restore the endocannabinoid system to treat dysfunction in the central nervous system.
Daily deal net: November 12, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Neuros Medical brainstorms $37m
Neuros Medical, a Case Western Reserve University spinout, has raised $69.8m since it was founded in 2008.

test reg

Login